Literature DB >> 7716706

Antiphospholipid antibodies and the antiphospholipid syndrome.

E N Harris1, S S Pierangeli.   

Abstract

The study of aPL antibodies and the APS has appealed to large numbers of investigators over the last decade. This accounts, in part, for the great degree of apparently contradictory data being published. What seems certain is that these antibodies are associated with thrombosis and recurrent pregnancy loss, and animal data suggest a direct role in pathogenesis. In vitro studies demonstrate that these antibodies have a variety of functional effects on the hemostatic system, giving further credence to an antibody role in thrombosis. Further studies will doubtless give better insight into the mechanisms of antibody action and this will provide a more rational basis for treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7716706     DOI: 10.1007/bf00197519

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  105 in total

1.  Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group.

Authors:  E N Harris
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

2.  Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria.

Authors:  J C Piette; B Wechsler; C Francis; P Godeau
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666

3.  Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant.

Authors:  E Marciniak; E H Romond
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

Review 4.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

5.  Effect of the lupus anticoagulant on endothelial fibrinolytic activity in vitro.

Authors:  R B Francis; S Neely
Journal:  Thromb Haemost       Date:  1989-04-25       Impact factor: 5.249

6.  Fatty acid chain is a critical epitope for antiphospholipid antibody.

Authors:  R A Levy; A E Gharavi; L R Sammaritano; L Habina; M D Lockshin
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

7.  Purification of anticardiolipin and lupus anticoagulant activities by using cardiolipin immobilized on agarose beads.

Authors:  V Pengo; A Biasiolo
Journal:  Thromb Res       Date:  1993-12-01       Impact factor: 3.944

8.  Inhibition of prothrombin activation by antiphospholipid antibodies and beta 2-glycoprotein 1.

Authors:  G H Goldsmith; S S Pierangeli; D W Branch; A E Gharavi; E N Harris
Journal:  Br J Haematol       Date:  1994-07       Impact factor: 6.998

9.  Antithrombin III in systemic lupus erythematosus.

Authors:  M L Boey; S Loizou; C B Colaco; J A Matkin; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1984 Jan-Mar       Impact factor: 4.473

10.  Activation of human platelets by the rabbit anticardiolipin antibodies.

Authors:  Y L Lin; C T Wang
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

View more
  7 in total

1.  Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome.

Authors:  Cai-Sheng Lu; Arash A Horizon; Kwan-Ki Hwang; John FitzGerald; Wei-Shiang Lin; Bevra H Hahn; Daniel J Wallace; Allan L Metzger; Michael H Weisman; Pojen P Chen
Journal:  Arthritis Rheum       Date:  2005-12

2.  Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

Authors:  S Hörkkö; E Miller; E Dudl; P Reaven; L K Curtiss; N J Zvaifler; R Terkeltaub; S S Pierangeli; D W Branch; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins).

Authors:  S Hörkkö; E Miller; D W Branch; W Palinski; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 4.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

5.  A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice.

Authors:  T Olee; S S Pierangeli; H H Handley; D T Le; X Wei; C J Lai; J En; W Novotny; E N Harris; V L Woods; P P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

6.  Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.

Authors:  Wei-Shiang Lin; Pei-Chih Chen; Cheng-De Yang; EunJung Cho; Bevra H Hahn; Jennifer Grossman; Kwan-Ki Hwang; Pojen P Chen
Journal:  Arthritis Rheum       Date:  2007-05

7.  Plasmin immunization preferentially induces potentially prothrombotic IgG anticardiolipin antibodies in MRL/MpJ mice.

Authors:  Kaleo Ede; Kwan-Ki Hwang; Chen-Ching Wu; Meifang Wu; Yao-Hsu Yang; Wei-Shiang Lin; Daniel Chien; Pei-Chih Chen; Betty P Tsao; Deborah K McCurdy; Pojen P Chen
Journal:  Arthritis Rheum       Date:  2009-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.